This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Mixis France S.a., Deinove. Active years: 1999-2015.
Location History:
- Gentilly, FR (2011)
- Paris, FR (1999 - 2015)
Company Filing History:
Years Active: 1999-2015
Title: Miroslav Radman: Innovator in Chromosomal Engineering
Introduction
Miroslav Radman is a prominent inventor based in Paris, France. He has made significant contributions to the field of genetic engineering, particularly in the area of DNA repair processes. With a total of 4 patents, Radman's work has the potential to revolutionize genetic manipulation techniques.
Latest Patents
One of his latest patents is titled "Process for chromosomal engineering using a novel DNA repair system." This invention focuses on chromosomal engineering through a DNA repair process. The process involves several steps, including submitting biological activity sources to radiation or chemical treatment to damage DNA, annealing complementary single strand tails, and converting long linear DNA intermediates into intact circular chromosomes. Additionally, foreign genetic material can be introduced during the process, enhancing its versatility. Another notable patent is "Process for the reversible functional inactivation of the mismatch repair system." This invention allows for homologous recombination between non-identical DNA sequences, opening up various applications in genetic research.
Career Highlights
Throughout his career, Miroslav Radman has worked with several companies, including Mixis France S.A. and Deinove. His innovative approaches and research have positioned him as a key figure in the field of genetic engineering.
Collaborations
Radman has collaborated with notable colleagues such as Christiane Rayssiguier and Ksenija Zahradka. These partnerships have further enriched his research and contributed to advancements in genetic engineering.
Conclusion
Miroslav Radman's contributions to chromosomal engineering and DNA repair processes highlight his role as a leading inventor in the field. His innovative patents and collaborations continue to influence genetic research and applications.